Traditional Chinese medicine composition for treating malignant pleural effusion and application thereof

A malignant pleural effusion and composition technology, applied in drug combinations, blood diseases, anti-tumor drugs, etc., to achieve the effect of convenient use, definite curative effect, and high patient compliance

Inactive Publication Date: 2019-08-09
JINSHAN HOSPITAL FUDAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But about the application of Chinese medicine composition of the present inv

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for treating malignant pleural effusion and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1 treats the Chinese medicine composition (one) of malignant pleural effusion

[0025] 30 parts of Nansha Ginseng, 30 parts of Beisha Ginseng, 12 parts of Asparagus, 12 parts of Ophiopogon japonicus, 6 parts of Lycium barbarum, 12 parts of Dendrobium, 30 parts of Shandougen, 12 parts of Bai Ying, 12 parts of almond, 30 parts of whole Trichosanthes, Banzhilian 12 parts, Agrimony 9 parts, Morus alba 30 parts, Solanum nigrum 30 parts, Tinglizi 12 parts, decoct according to the conventional method.

Embodiment 2

[0026] Embodiment 2 treats the Chinese medicine composition (two) of malignant pleural effusion

[0027] 27 parts of Nansha ginseng, 27 parts of Beisha ginseng, 9 parts of Asparagus, 9 parts of Ophiopogon japonicus, 3 parts of wolfberry, 12 parts of dendrobium, 30 parts of mountain bean root, 12 parts of white flower, 12 parts of almond, 30 parts of whole Trichosanthes, Banzhilian 15 parts, Agrimony 12 parts, Morus Alba 33 parts, Solanum nigrum 33 parts, Tinglizi 15 parts, decoct according to conventional methods.

Embodiment 3

[0028] Embodiment 3 treats the Chinese medicine composition (three) of malignant pleural effusion

[0029] 30 parts of Nansha ginseng, 30 parts of Beisha ginseng, 12 parts of Asparagus, 12 parts of Ophiopogon japonicus, 6 parts of wolfberry, 15 parts of Dendrobium, 33 parts of mountain bean root, 15 parts of Baiying, 15 parts of almond, 33 parts of whole Trichosanthes, Scutellaria barbata 9 parts, Agrimony 6 parts, Morus alba 27 parts, Solanum nigrum 27 parts, Tinglizi 9 parts, decoct according to conventional methods.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a traditional Chinese medicine composition for treating malignant pleural effusion. The traditional Chinese medicine composition is prepared from, by weight, 27-33 parts of radix adenophorae, 27-33 parts of radix glehniae, 9-15 parts of radix asparagi, 9-15 parts of radix ophiopogonis, 3-9 parts of lycium chinense, 9-15 parts of herba dendrobii, 27-33 parts of radix sophorae tonkinensis, 9-15 parts of bittersweet herb, 9-15 parts of apricot kernels, 27-33 parts of trichosanthes kirilowii, 9-15 parts of herba scutellariae barbatae, 6-12 parts of herba agrimoniae, 27-33parts of cortex mori, 27-33 parts of black nightshade herb and 9-15 parts of semen lepidii. The invention further relates to application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is obtained by combining the fifteen medicinal materials and has the functions of nourishing yin to clear away the lung-heat, ventilating the lung to resolve phlegm, clearing away heat and toxic materials and purging the lung for diuresis. For malignant pleural effusion, by purging the lung for diuresis, dampness can be removed from the external genitalia and phlegmcan be dissolved from the lungs so as to dispel pathogenic effusion. After the traditional Chinese medicine composition is taken for 8 weeks, the total effective rate of patients reaches 88.54%, the disease remission rate is 98.96%, and no obvious adverse reaction is found, which proves that the traditional Chinese medicine composition can effectively reduce pleural effusion, remit symptoms and maintain the patients' condition stable.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating malignant pleural effusion and its application. Background technique [0002] A normal healthy person maintains 3-15ml of trace fluid in the thorax, which plays a lubricating role during breathing. Part of this trace fluid is absorbed by the capillaries in the chest cavity, and the other part is recycled by the lymphatic system. Normally, the fluid in the chest cavity is in a state of dynamic balance. When a disease occurs in the body, the dynamic balance is out of balance, resulting in too fast or slow absorption of fluid in the pleural cavity, which is clinically called pleural effusion. [0003] Malignant pleural effusions refer to pleural effusions caused by lung cancer or other malignant tumors involving the pleura or primary pleural tumors. Almost all malignant tumors except primary brain tumors...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8984A61P7/10A61P35/00
CPCA61K36/23A61K36/31A61K36/342A61K36/428A61K36/489A61K36/539A61K36/605A61K36/73A61K36/736A61K36/81A61K36/815A61K36/8965A61K36/8968A61K36/8984A61P7/10A61P35/00A61K2300/00
Inventor 张洁
Owner JINSHAN HOSPITAL FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products